TrialThe oncologist2020

Predictive Impact of Mucinous Tumors on the Clinical Outcome in Patients with Poorly Differentiated, Stage II Colon Cancer: A TOSCA Subgroup Analysis.

Gerardo Rosati et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.